Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Conditions
Coagulopathy - Mesothelioma
Conditions: official terms
Blood Coagulation Disorders - Hemostatic Disorders - Mesothelioma
Study Type
Observational
Study Phase
Phase 0
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Intervention
Name: Blood draw for TEG analysis
Type: Procedure
Overall Status
Recruiting
Summary
Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve significant blood loss with considerable blood and product transfusion. Thromboelastography (TEG) is a global assay of coagulation that uses whole blood to produce a tracing that records kinetic changes in clot formation. This study aims provide a better understanding of the coagulation profile of these patients, and will form the basis of a TEG-based transfusion algorithm for future surgeries for mesothelioma.
Detailed Description
Thromboelastography can provide more in-depth and quicker analysis of the complex coagulation processes during surgery
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Adult male or female patients undergoing elective surgery for malignant pleural mesothelioma

Exclusion Criteria:

- Unwilling or unable to provide consent

- History of bleeding disorder

- On medications that may affect hemostasis
Location
Brigham and Women's Hospital
Boston, Massachusetts, United States
Status: Recruiting
Contact: Ju-Mei Ng, MD - 617-732-8219 - jng1@partners.org
Start Date
September 2013
Completion Date
December 2015
Sponsors
Brigham and Women's Hospital
Source
Brigham and Women's Hospital
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page